Fresenius: upbeat after Q3 results

(CercleFinance.com) - Fresenius shares are up over 5% in Frankfurt today, with the healthcare group reporting EPS before non-recurring items down 8% to E0.
61, although a recurring EBIT margin that is up 0.5 point at 9.4%.

Sales rose by 2% (+6% at constant exchange rates and on an organic basis) to E5.52bn, driven by the operating companies and Fresenius Vamed, whose transformation is progressing, the German group says.

On this basis, Fresenius has improved its earnings outlook for 2023, now expecting EBIT at constant exchange rates to be pretty flat, for organic revenue growth still expected in the mid-single-digit range.


Copyright (c) 2023 CercleFinance.com. All rights reserved.